Human lymphocytes are resistant to genetic modification, particularly from recombinant adenoviruses, thus hampering the analysis of gene function using adenoviral vectors. This study engineered an Epstein–Barr virus-transformed B-lymphoblastoid cell line permissive to adenovirus infection and elucidated key roles for both the coxsackie–adenovirus receptor and αvβ5 integrin in mediating entry of adenoviruses into these cells. The work identified a strategy for engineering B cells to become susceptible to adenovirus infection and showed that such a strategy could be useful for the introduction of genes to alter lymphoblastoid-cell gene expression.
Ben-BassatH. N.,
GoldblumS.,
MitraniT.7 other authors1977; Establishment in continuous culture of a new type of lymphocyte from a “Burkitt like” malignant lymphoma (line D.G.-75). Int J Cancer 19:27–33[CrossRef]
BergelsonJ. M.,
CunninghamJ. A.,
DroguettG.,
Kurt-JonesE. A.,
KrithivasA.,
HongJ. S.,
HorwitzM. S.,
CrowellR. L.,
FinbergR. W.1997; Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323[CrossRef]
BewleyM. C.,
SpringerK.,
ZhangY. B.,
FreimuthP.,
FlanaganJ. M.1999; Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286:1579–1583[CrossRef]
ChretienI.,
MarcuzA.,
CourtetM.,
KatevuoK.,
VainioO.,
HeathJ. K.,
WhiteS. J.,
Du PasquierL.1998; CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates. Eur J Immunol 28:4094–4104[CrossRef]
CohenC. J.,
ShiehJ. T.,
PicklesR. J.,
OkegawaT.,
HsiehJ. T.,
BergelsonJ. M.2001; The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 98:15191–15196[CrossRef]
DidcockL.,
YoungD. F.,
GoodbournS.,
RandallR. E.1999; The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–9933
FuxeJ.,
LiuL.,
MalinS.,
PhilipsonL.,
CollinsV. P.,
PetterssonR. F.2003; Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int J Cancer 103:723–729[CrossRef]
HondaT.,
SaitohH.,
MasukoM.8 other authors2000; The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 77:19–28[CrossRef]
HongS. S.,
KarayanL.,
TournierJ.,
CurielD. T.,
BoulangerP. A.1997; Adenovirus type 5 fiber knob binds to MHC class I α 2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J 16:2294–2306[CrossRef]
HurezV.,
Dzialo-HattonR.,
OliverJ.,
MatthewsR. J.,
WeaverC. T.2002; Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model. BMC Immunol 3:4[CrossRef]
LeonR. P.,
HedlundT.,
MeechS. J.,
LiS.,
SchaackJ.,
HungerS. P.,
DukeR. C.,
DeGregoriJ.1998; Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A 95:13159–13164[CrossRef]
McDonaldD.,
StockwinL.,
MatzowT.,
Blair ZajdelM. E.,
BlairG. E.1999; Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells. Gene Ther 6:1512–1519[CrossRef]
RoweM.,
JonesM.2001; Detection of EBV latent proteins by Western Blotting. In Methods in Molecular Biology vol 174Epstein-Barr, Virus Protocolspp. 229–242 Edited by
WilsonJ. B.
Totowa: Humana Press;
RoweM.,
LearA. L.,
Croom-CarterD.,
DaviesA. H.,
RickinsonA. B.1992; Three pathways of Epstein–Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122–131
SegermanA.,
MeiY.-F.,
WadellG.2000; Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines. J Virol 74:1457–1467[CrossRef]
SpillerO. B.,
GoodfellowI. G.,
EvansD. J.,
HinchliffeS. J.,
MorganB. P.2002; Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF. J Gen Virol 83:45–52
StevensonS. C.,
RollenceM.,
WhiteB.,
WeaverL.,
McClellandA.1995; Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J Virol 69:2850–2857
TakayamaK.,
UenoH.,
PeiX. H.,
NakanishiY.,
YatsunamiJ.,
HaraN.1998; The levels of integrin α vβ 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells. Gene Ther 5:361–368[CrossRef]
van RaaijM. J.,
ChouinE.,
van der ZandtH.,
BergelsonJ. M.,
CusackS.2000; Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1·7 Å resolution. Structure Fold Des 8:1147–1155[CrossRef]
WangX.,
BergelsonJ. M.1999; Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J Virol 73:2559–2562
WhiteR. E.,
Wade-MartinsR.,
JamesM. R.2002; Infectious delivery of 120-kilobase genomic DNA by an Epstein–Barr virus amplicon vector. Mol Ther 5:427–435[CrossRef]
WickhamT. J.,
MathiasP.,
ChereshD. A.,
NemerowG. R.1993; Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment. Cell 73:309–319[CrossRef]
WilkinsonG. W.,
AkriggA.1992; Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20:2233–2239[CrossRef]